New leads to cancer, arthritis therapies.
Hagmann
M
M
D051722:ADAM Proteins; D000071121:ADAMTS4 Protein; D000818:Animals; D000970:Antineoplastic Agents; D018501:Antirheumatic Agents; D001168:Arthritis / Q000188:drug therapy*; D001665:Binding Sites; D003001:Cloning, Molecular; D004792:Enzyme Precursors / Q000737:chemistry / Q000378:metabolism; D018093:Gelatinases / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D020778:Matrix Metalloproteinase 2; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008958:Models, Molecular; D009369:Neoplasms / Q000188:drug therapy*; D011348:Procollagen N-Endopeptidase; D011480:Protease Inhibitors / Q000494:pharmacology*; D011487:Protein Conformation; D017433:Protein Structure, Secondary
D000970:Antineoplastic Agents; D018501:Antirheumatic Agents; D004792:Enzyme Precursors; D011480:Protease Inhibitors; D051722:ADAM Proteins; D018093:Gelatinases; D008666:Metalloendopeptidases; D011348:Procollagen N-Endopeptidase; D020778:Matrix Metalloproteinase 2; D000071121:ADAMTS4 Protein